Nonlinear pharmacokinetics of rituximab in anti-neutrophil cytoplasmic antibody associated vasculitis.

Denis Mulleman 1, 2 Amina Bensalem 2 David Ternant 3, 2 Gilles Paintaud 3, 2 Divi Cornec 4, 5 Ulrich Specks 6
1 Service de rhumatologie [Tours]
2 GICC EA 7501 - Groupe innovation et ciblage cellulaire (GICC), EA 7501 [2018-...]
3 Laboratoire de Pharmacologie-Toxicologie [CHRU Tours]
4 LBAI - Lymphocyte B et Auto-immunité
5 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie
6 Mayo Clinic [Rochester]
Document type :
Poster communications
Complete list of metadatas
https://hal.univ-brest.fr/hal-02151041
Contributor : Geneviève Michel <>
Submitted on : Friday, June 7, 2019 - 4:17:55 PM
Last modification on : Monday, December 9, 2019 - 10:52:54 AM

Identifiers

  • HAL Id : hal-02151041, version 1

Collections

UNIV-BREST | CNRS | IMMUNO | IBSAM | UNIV-TOURS

Citation

Denis Mulleman, Amina Bensalem, David Ternant, Gilles Paintaud, Divi Cornec, et al.. Nonlinear pharmacokinetics of rituximab in anti-neutrophil cytoplasmic antibody associated vasculitis.. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02151041⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

27

Contact

Informations

CCSD